Study protocol: phase 1 dose escalating study of Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) with oxaliplatin in peritoneal metastasis
DURVIT': a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironment | BMC Cancer | Full Text
A hybrid design for dose‐finding oncology clinical trials - Liao - 2022 - International Journal of Cancer - Wiley Online Library
Flexibility of the BLRM in Dose-Escalation Trials
Adaptive design for identifying maximum tolerated dose early to accelerate dose-finding trial | BMC Medical Research Methodology | Full Text
Recommended dosages in each arm. DLT, dose-limiting toxicity; RD,... | Download Scientific Diagram
A Multicenter Phase I/II Study of Obatoclax Mesylate Administered as a 3- or 24-Hour Infusion in Older Patients with Previously Untreated Acute Myeloid Leukemia | PLOS ONE
Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trial - eClinicalMedicine
Phase I trials - memoinOncology
1. Given the true DLT rate, calculate the probability | Chegg.com
Study design for dose-escalation cohorts and DLT rate (as calculated by... | Download Scientific Diagram
Autolack Dose spritzfertig für Ford DLT Gelb Basislack 1,0 Liter 1000ml : Amazon.de: Auto & Motorrad
Innovative design for a phase 1 trial with intra-patient dose escalation: The Crotoxin study - ScienceDirect
Biostatistical intepretation series II Clinical Trials Phase I - mitigating misinterpretation risk in dose escalation studies
Outline
Exposure driven dose escalation design with overdose control: Concept and first real life experience in an oncology phase I trial - ScienceDirect
Principles of dose finding studies in cancer: a comparison of trial designs | Cancer Chemotherapy and Pharmacology
Innovative design for a phase 1 trial with intra-patient dose escalation: The Crotoxin study. - Abstract - Europe PMC
Three-plus-three dose escalation design. DLT, dose-limiting toxicity;... | Download Scientific Diagram
Study flow chart. DLT, dose-limiting toxicity. | Download Scientific Diagram
Frontiers | A Dose-Finding Trial for Hyperthermic Intraperitoneal Cisplatin in Gynecological Cancer Patients Receiving Hyperthermic Intraperitoneal Chemotherapy
Bayesian Optimal Interval Design: A Simple and Well-Performing Design for Phase I Oncology Trials. - Abstract - Europe PMC
